title: In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy.
authors.affiliation: Johnson and Johnson Research Pty Ltd, Australian Technology Park, Eveleigh, NSW, Australia. tapplegate@nchecr.unsw.edu.au
authors.forename: Tanya Lynn
authors.initials: TL
authors.lastname: Applegate
authors.forename: Donald John
authors.initials: DJ
authors.lastname: Birkett
authors.forename: Glen John
authors.initials: GJ
authors.lastname: Mcintyre
authors.forename: Angel Belisario
authors.initials: AB
authors.lastname: Jaramillo
authors.forename: Geoff
authors.initials: G
authors.lastname: Symonds
authors.forename: John Michael
authors.initials: JM
authors.lastname: Murray